The KMT2A gene, once termed a mixed-lineage leukemia (MLL) gene, is well known for its promiscuity, as it fuses with over 100 partner genes with numerous breakpoints in the context of hematological malignancies [64], giving rise to challenges in detection with conventional diagnostic methods. This evidence concerns the gene KMT2A and hematologic disorder.